| 000 | 01844 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517074019.0 | ||
| 264 | 0 | _c20161014 | |
| 008 | 201610s 0 0 eng d | ||
| 022 | _a1573-7217 | ||
| 024 | 7 |
_a10.1007/s10549-016-3685-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKotsopoulos, Joanne | |
| 245 | 0 | 0 |
_aHormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study. _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cJan 2016 |
||
| 300 |
_a365-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBRCA1 Protein _xgenetics |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHormone Replacement Therapy _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMenopause _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aHuzarski, Tomasz | |
| 700 | 1 | _aGronwald, Jacek | |
| 700 | 1 | _aMoller, Pal | |
| 700 | 1 | _aLynch, Henry T | |
| 700 | 1 | _aNeuhausen, Susan L | |
| 700 | 1 | _aSenter, Leigha | |
| 700 | 1 | _aDemsky, Rochelle | |
| 700 | 1 | _aFoulkes, William D | |
| 700 | 1 | _aEng, Charis | |
| 700 | 1 | _aKarlan, Beth | |
| 700 | 1 | _aTung, Nadine | |
| 700 | 1 | _aSinger, Christian F | |
| 700 | 1 | _aSun, Ping | |
| 700 | 1 | _aLubinski, Jan | |
| 700 | 1 | _aNarod, Steven A | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 155 _gno. 2 _gp. 365-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-016-3685-3 _zAvailable from publisher's website |
| 999 |
_c25642545 _d25642545 |
||